Literature DB >> 17275961

Patient outcomes after simultaneous bilateral total hip and knee joint replacements.

K Huotari1, O Lyytikäinen, S Seitsalo.   

Abstract

Simultaneous arthroplasties are increasingly being performed during one single anaesthetic event. No national nosocomial surveillance systems have yet reported data on this issue. We compared patient populations undergoing bi- and unilateral total hip (THA) and total knee (TKA) arthroplasties in terms of two outcome variables, deep surgical site infections (SSI) and mortality, by analysing surveillance data from the Finnish Hospital Infection Programme (SIRO). A total of 8201 patients underwent 9831 total arthroplasties during 2001-2004. Of the prosthetic joints, 7.2% were inserted in a bilateral operation (range by hospital, 0.6-19.2%; range by procedure type, 5.2-9.9%). Patients who underwent bilateral operations were younger; more often males, and their ASA score was lower than those who underwent unilateral procedures. The rate of deep SSI in bi- and unilateral THAs and in bi- and unilateral TKAs was 0, 0.5, 1.0 and 0.9%, respectively. Following bilateral operations, four deep SSIs were detected, all from bilateral TKAs, three of which were on the second operative side. In these three cases, single doses of antimicrobial prophylaxis were administered 115, 155 and 218 min before incision (median time in unilateral operations: 47 min). According to multi-variate analysis, bilateral operations were not an independent risk factor for deep SSIs. Mortality did not differ between bi- and unilateral THAs or TKAs. Our surveillance data indicate that simultaneous bilateral surgery did not increase the risk of deep SSIs or death after THA and TKA. Bilateral operations may, however, require specific guidelines regarding antimicrobial prophylaxis.

Entities:  

Mesh:

Year:  2007        PMID: 17275961     DOI: 10.1016/j.jhin.2006.10.018

Source DB:  PubMed          Journal:  J Hosp Infect        ISSN: 0195-6701            Impact factor:   3.926


  7 in total

1.  The relative safety of one-stage bilateral total knee arthroplasty.

Authors:  J C Luscombe; K Theivendran; A Abudu; S R Carter
Journal:  Int Orthop       Date:  2007-09-14       Impact factor: 3.075

2.  In-hospital complications and mortality of unilateral, bilateral, and revision TKA: based on an estimate of 4,159,661 discharges.

Authors:  Stavros G Memtsoudis; Alejandro González Della Valle; Melanie C Besculides; Licia Gaber; Thomas P Sculco
Journal:  Clin Orthop Relat Res       Date:  2008-08-14       Impact factor: 4.176

3.  Is simultaneous bilateral total knee arthroplasty safe in geriatric population? A retrospective cohort study with upto 9 years follow up.

Authors:  Raju Vaishya; Vipul Vijay; Kapil Mani K C; Amit Kumar Agarwal
Journal:  J Clin Orthop Trauma       Date:  2017-06-01

4.  Analysis of Interlimb Asymmetry in Patients Undergoing Simultaneous Bilateral Total Knee Arthroplasty.

Authors:  Yu Yang; Gong Long; Wang Zhenhu
Journal:  PLoS One       Date:  2015-06-24       Impact factor: 3.240

5.  Postoperative Complications and Cost-effectiveness of Simultaneous and Staged Bilateral Total Hip Arthroplasty Using a Modified Minimally Invasive Two-incision Technique.

Authors:  Jong Hwan Seol; Kyung Soon Park; Taek Rim Yoon
Journal:  Hip Pelvis       Date:  2015-06-30

6.  Prosthetic joint infection development of an evidence-based diagnostic algorithm.

Authors:  Heinrich M L Mühlhofer; Florian Pohlig; Karl-Georg Kanz; Ulrich Lenze; Florian Lenze; Andreas Toepfer; Sarah Kelch; Norbert Harrasser; Rüdiger von Eisenhart-Rothe; Johannes Schauwecker
Journal:  Eur J Med Res       Date:  2017-03-09       Impact factor: 2.175

7.  [Diagnosis of periprosthetic joint infection : Development of an evidence-based algorithm by the work group of implant-associated infection of the AE-(German Society for Arthroplasty)].

Authors:  H Mühlhofer; N Renz; A Zahar; M Lüdemann; M Rudert; R Hube; L Frommelt; R Ascherl; C Perka; R von Eisenhart-Rothe
Journal:  Orthopade       Date:  2021-04       Impact factor: 1.087

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.